Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Corrects Nasdaq Non-Compliance by Naming Director

NEW YORK (GenomeWeb News) — Genetic Technologies today said it has corrected its “brief non-compliance” with the Nasdaq exchange by appointing a director and audit committee chairman.
 
The firm appointed David Carruthers, who formerly was CFO and European regional CEO for BP Finance, and was managing director of the Treasury Corporation of Victoria, Australia.
 
Carruthers also serves on the audit committee for Ceramic Fuel Cells and is a non-executive director for India Equities Fund.
 
Nasdaq's rule specifies that listed companies must maintain an audit board of at least three members who fit certain specifications, and maintains that at least one member of that board must have an acceptable background in accounting or finance.
 
Genetic Technologies said on Jan. 12 that it was not in compliance with this requirement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.